Release Date: 18/11/14 09:16 Summary: Final results from 2014 phase 2 drill program - Woolgar Price Sensitive: Yes Download Document 4.51MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%